| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $932 | $871 | $770 | $939 |
| Inventory | $7806 | $5706 | $5225 | $4958 |
| Total current assets | $9955 | $8562 | $7753 | $7897 |
| Long term investments | ||||
| Property, plant & equipment | $5038 | $5043 | $4967 | $5018 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $17018 | $15624 | $14752 | $14967 |
| Current liabilities | ||||
| Accounts payable | $7145 | $5542 | $4664 | $4637 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $9948 | $8451 | $7649 | $7909 |
| Long term debt | $1144 | $1157 | $1134 | $1152 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $13936 | $12517 | $11670 | $11914 |
| Shareholders' equity | ||||
| Retained earnings | $2775 | $2722 | $2683 | |
| Other shareholder equity | $3082 | $3107 | $3082 | $317 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 3 Mar 2024 | 28 Feb 2023 | 1 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1033 | |||
| Short term investments | ||||
| Net receivables | $939 | $1141 | $1042 | |
| Inventory | $4958 | $5140 | $5965 | |
| Total current assets | $7897 | $8802 | $10539 | |
| Long term investments | $566 | |||
| Property, plant & equipment | $5018 | $5098 | $4904 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14967 | $15803 | $17504 | |
| Current liabilities | ||||
| Accounts payable | $4637 | $5687 | $6803 | |
| Deferred revenue | ||||
| Short long term debt | $40 | |||
| Total current liabilities | $7909 | $8979 | $10674 | |
| Long term debt | $1152 | $1160 | $1216 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $11914 | $13008 | $14484 | |
| Shareholders' equity | ||||
| Retained earnings | $2683 | $2430 | $2668 | |
| Other shareholder equity | $317 | $2795 | $329 | |
| Total shareholder equity | $1369 | |||
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8847 | $14646 | ||
| Cost of revenue | ||||
| Gross Profit | $2064 | $3001 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $1737 | $2271 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $80 | $124 | ||
| Interest expense | $13 | $23 | ||
| Net income | ||||
| Net income | $246 | $460 | ||
| Income (for common shares) | ||||
| (in millions $) | 3 Mar 2024 | 28 Feb 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $43452 | $46298 | $7185 | $7320 |
| Cost of revenue | $6946 | $7079 | ||
| Gross Profit | $9603 | $9912 | $239 | $241 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $7876 | $7970 | $7177 | $7311 |
| Operating income | $8 | $9 | ||
| Income from continuing operations | ||||
| EBIT | $8 | $9 | ||
| Income tax expense | $381 | $370 | -$52 | $18 |
| Interest expense | $26 | -$7 | -$45 | -$42 |
| Net income | ||||
| Net income | $1241 | $1419 | $140 | $30 |
| Income (for common shares) | $140 | $30 | ||
| (in millions $) | 2 Dec 2024 | 3 Sep 2024 | 4 Jun 2024 | 3 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$522 | -$352 | -$167 | -$781 |
| Financing activities | ||||
| Dividends paid | -$607 | -$405 | -$202 | -$801 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$892 | -$557 | -$252 | -$1144 |
| Effect of exchange rate | -$2 | -$3 | -$3 | -$5 |
| Change in cash and equivalents | -$855 | -$95 | -$266 | -$460 |
| (in millions $) | 3 Mar 2024 | 28 Feb 2023 | 30 Dec 2021 | 30 Dec 2020 |
|---|---|---|---|---|
| Net income | $140 | $30 | ||
| Operating activities | ||||
| Depreciation | $88 | $90 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $353 | $274 | ||
| Investing activities | ||||
| Capital expenditures | -$35 | -$33 | ||
| Investments | $52 | -$7 | ||
| Total cash flows from investing | -$781 | -$962 | $116 | $7 |
| Financing activities | ||||
| Dividends paid | -$801 | -$789 | -$29 | -$6 |
| Sale and purchase of stock | ||||
| Net borrowings | -$51 | -$92 | ||
| Total cash flows from financing | -$1144 | -$1806 | -$266 | -$253 |
| Effect of exchange rate | -$5 | -$8 | $4 | -$14 |
| Change in cash and equivalents | -$460 | -$952 | $207 | $14 |
| Market cap | $154.82B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 214.73M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.00 |
| Quick ratio | 0.22 |